Answers are grounded in this paper and cite their sources.
Results supported a demonstration of PK similarity between candidate biosimilar AVT04, US-RP and EU-RP. Similar safety and immunogenicity were also shown.Clinical trial registration: www.clinicaltrials.gov identifier is NCT04744363.
No takes yet. Share an insight, caveat, or question.
Wynne et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: